lysyl-aspartyl-glutamyl-leucine has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Rosa, SC; Hamer, DH; Lueders, KK; Pavlakis, GN; Roederer, M; Valentin, A | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and HIV Coinfection
Article | Year |
---|---|
A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types.
Topics: ADP Ribose Transferases; Animals; Antiretroviral Therapy, Highly Active; Bacterial Toxins; Cells, Cultured; Chemotherapy, Adjuvant; CHO Cells; Cricetinae; Exotoxins; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunotoxins; In Vitro Techniques; Leukocytes, Mononuclear; Luminescent Proteins; Lymphocyte Subsets; Oligopeptides; Protein Sorting Signals; Pseudomonas aeruginosa Exotoxin A; Virulence Factors | 2004 |